Mayne Pharma acquires Metrics, Inc. – CDMO with niche generic product portfolio and pipeline.
Acquired DORYX® brand and related assets in the US from Actavis.
Mayne Pharma acquires US portfolio of products from Teva and Allergan in the US.
Mayne Pharma acquires US foam dermatology products from GSK – FABIOR® and SORILUX®.
New solid oral dose manufacturing facility in Greenville, NC, USA opened.